1. The implications of the coronavirus pandemic for the environment  Business Standard
  2. This Image Shows SARS-CoV-2 Conquering A Human Lung Cell  IFLScience
  3. Can you catch COVID-19 from your neighbor's toilet?  Science Magazine
  4. The Covid-19 virus is deadliest if you are older and male - scientists looked at the risks  Health24
  5. Clinical Trial Testing Eli Lilly's LY-CoV555 Antibody Against SARS-CoV-2 / COVID-19 Begins  SciTechDaily
  6. View Full coverage on Google News
Read more about The implications of the coronavirus pandemic for the environment on Business Standard. Challenges at the intersection of health, ecology, and climate scienceChallenges at the intersection of health, ecology, and climate science

The implications of the coronavirus pandemic for the environment | Business Standard News

You're looking at SARS-CoV-2, the coronavirus responsible for Covid-19 that’s no doubt not only ruined your 2020, but changed the world.  Reported in the NYou're looking at SARS-CoV-2, the coronavirus responsible for Covid-19 that’s no doubt not only ruined your 2020, but changed the world.  Reported in the N

This Image Shows SARS-CoV-2 Conquering A Human Lung Cell | IFLScience

A detailed analysis of existing Covid-19 studies shows that age is by far the strongest predictor of an infected person’s risk of dying. A detailed analysis of existing Covid-19 studies shows that age is by far the strongest predictor of an infected person’s risk of dying.

The Covid-19 virus is deadliest if you are older and male - scientists looked at the risks | Health24

Study to test Eli Lilly and Company's LY-CoV555, a human monoclonal antibody against the SARS-CoV-2 spike protein, will examine its ability to combat the virus in mild to moderate cases of COVID-19. The University of Chicago Medicine is launching a clinical trial to examine the potential of an an

Clinical Trial Testing Eli Lilly's LY-CoV555 Antibody Against SARS-CoV-2 / COVID-19 Begins

Clinical Trial Testing Eli Lilly’s LY-CoV555 Antibody Against SARS-CoV-2 / COVID-19 Begins – SciTechDaily

Study on Covid in Iceland published in New England Journal of Medicine shows immunity lasts longer and reinfections are indeed rare.Study on Covid in Iceland published in New England Journal of Medicine shows immunity lasts longer and reinfections are indeed rare.

There's very good news about coronavirus immunity & reinfection, Iceland study says

Study on Covid in Iceland published in New England Journal of Medicine shows immunity lasts longer and reinfections are indeed rare.Study on Covid in Iceland published in New England Journal of Medicine shows immunity lasts longer and reinfections are indeed rare.

There's very good news about coronavirus immunity & reinfection, Iceland study says

Some doctors believe most relapses will be milder than the first infection and this weakening depends on our body learning to fight the virusSome doctors believe most relapses will be milder than the first infection and this weakening depends on our body learning to fight the virus

Good news from Iceland about getting the coronavirus twice

Study suggesting virus spread through waste pipes in Chinese apartment building raises concernsStudy suggesting virus spread through waste pipes in Chinese apartment building raises concerns

Can you catch COVID-19 from your neighbor’s toilet? | Science | AAAS

SARS-CoV-2, the coronavirus responsible for the disease COVID-19, is infecting the world at a rapid rate. Understanding how this infection works at the molecular level could help experts discover ways ...

Neutrons probe biological materials for insights into COVID-19 virus infection

Second infections raise questions about long-term immunity to COVID-19 and the prospects for a vaccine. Second infections raise questions about long-term immunity to COVID-19 and the prospects for a vaccine.Second infections raise questions about long-term immunity to COVID-19 and the prospects for a vaccine.

Coronavirus reinfections: three questions scientists are asking

An infection with the coronavirus SARS-CoV-2 can affect multiple organs. With this in mind, researchers of the German Center for Neurodegenerative Diseases and Cornell University in the US have investigated cellular factors that could be significant for an infection.An infection with the coronavirus SARS-CoV-2 can affect multiple organs. With this in mind, researchers of the German Center for Neurodegenerative Diseases and Cornell University in the US have investigated cellular factors that could be significant for an infection.

Research provides a map of coronavirus entry factors across the human body

While there are anecdotes aplenty, there's also some solid science behind the worries.While there are anecdotes aplenty, there's also some solid science behind the worries.

Evidence slowly building for long-term heart problems post-COVID-19 | Ars Technica

While there are anecdotes aplenty, there's also some solid science behind the worries.While there are anecdotes aplenty, there's also some solid science behind the worries.

Evidence slowly building for long-term heart problems post-COVID-19 | Ars Technica

Vaccine may strengthen immune response to viral infections; trial to enroll up to 30,000 health-care workers

Global trial to test whether MMR vaccine protects front-line health-care workers against COVID-19 – Washington University School of Medicine in St. Louis

The first case of apparent reinfection with SARS-CoV-2 in the United States has prompted scientists to consider what this phenomenon might indicate.The first case of apparent reinfection with SARS-CoV-2 in the United States has prompted scientists to consider what this phenomenon might indicate.

Alleged US case of SARS-CoV-2 reinfection raises questions

Careful sampling can detect the presence of the pathogen which would have travelled through a community’s sewage system to a treatment plant.

How Sewage Monitoring for COVID-19 Works - The Wire Science

The University of Chicago Medicine is launching a clinical trial to examine the potential of an antibody against the SARS-CoV-2 spike protein for treating COVID-19, the disease caused by the novel coronavirus.

Clinical trial testing efficacy of antibody against SARS-CoV-2 begins

There's a flood of new COVID-19 information coming at us every day, and the interpretation of it can get muddled downstream in the currents of public discourse. Here are a few creative ways the scientists are working to get the latest COVID-19 science out to the public.There's a flood of new COVID-19 information coming at us every day, and the interpretation of it can get muddled downstream in the currents of public discourse. Here are a few creative ways the scientists are working to get the latest COVID-19 science out to the public.

The science of keeping up with COVID-19 science | KSL.com

Here’s a closer look at the coronavirus that causes covid-19, courtesy of new research published this week.Here’s a closer look at the coronavirus that causes covid-19, courtesy of new research published this week.

Horrifying Images Show How the Coronavirus Ravages Our Lungs | Gizmodo UK

While the study at hand gives positive news, it is important to understand that it was conducted in a population where only 1 per cent of the total population has contracted SARS-CoV-2.While the study at hand gives positive news, it is important to understand that it was conducted in a population where only 1 per cent of the total population has contracted SARS-CoV-2.